Smaller aggregates (called sub-visible particles) are too small to see but still problematic
Although current evidence supports broad applicability across BMI, diabetes status, and fibrosis stages F2-F3, subgroup analyses suggest attenuated responses in non-obese patients and in certain ethnic groups (Hispanic patients in ESSENCE), emphasizing the need for precision medicine approaches incorporating anthropometric, genetic (e.g., PNPLA3, HSD17B13), and metabolic profiling
How Does That Compare to Injectables
Talk to your doctor: Discuss your financial situation with your doctor and explore potential cost-saving options
The primary and secondary endpoints were absolute change from baseline in body weight at week 48 and week 72, respectively
Step 2: The C18 column was washed with acetonitrile and 0.1% TFA solution